Graeme Brookes
Chief Executive Officer at Reapplix A/S
Graeme Brookes active positions
| Companies | Position | Start | End |
|---|---|---|---|
Reapplix A/S
 Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Chief Executive Officer | 2014-09-11 | - |
Career history of Graeme Brookes
Former positions of Graeme Brookes
| Companies | Position | Start | End |
|---|---|---|---|
The Acrobot Co. Ltd.
 The Acrobot Co. Ltd. Medical SpecialtiesHealth Technology The Acrobot Co. Ltd. develops precision surgical systems for minimally invasive, bone conserving and orthopedic surgery. It also assists surgeons in achieving better patient outcomes by improving surgical precision and reducing surgical errors. The company was founded by Brian Davies and Justin Cobb in 1999 and is headquartered in London, GB. | President | - | 2012-12-05 |
Statistics
International
| United Kingdom | 2 |
| Denmark | 2 |
Operational
| President | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 2 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
The Acrobot Co. Ltd.
The Acrobot Co. Ltd. Medical SpecialtiesHealth Technology The Acrobot Co. Ltd. develops precision surgical systems for minimally invasive, bone conserving and orthopedic surgery. It also assists surgeons in achieving better patient outcomes by improving surgical precision and reducing surgical errors. The company was founded by Brian Davies and Justin Cobb in 1999 and is headquartered in London, GB. | Health Technology |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Distribution Services |
- Stock Market
- Insiders
- Graeme Brookes
- Experience
